SG11201609382WA - Compositions and methods for stabilizing luminogenic substrates - Google Patents
Compositions and methods for stabilizing luminogenic substratesInfo
- Publication number
- SG11201609382WA SG11201609382WA SG11201609382WA SG11201609382WA SG11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA
- Authority
- SG
- Singapore
- Prior art keywords
- stabilizing
- compositions
- methods
- luminogenic substrates
- luminogenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Electroluminescent Light Sources (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462002363P | 2014-05-23 | 2014-05-23 | |
PCT/US2015/032439 WO2015179864A1 (fr) | 2014-05-23 | 2015-05-26 | Compositions et procédés de stabilisation de substrats luminogènes |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201609382WA true SG11201609382WA (en) | 2016-12-29 |
Family
ID=53434457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201609382WA SG11201609382WA (en) | 2014-05-23 | 2015-05-26 | Compositions and methods for stabilizing luminogenic substrates |
Country Status (10)
Country | Link |
---|---|
US (1) | US9676997B2 (fr) |
EP (1) | EP3146066B1 (fr) |
JP (1) | JP6641297B2 (fr) |
KR (1) | KR102456212B1 (fr) |
CN (1) | CN106661028B (fr) |
AU (1) | AU2015263901B2 (fr) |
BR (1) | BR112016027504B1 (fr) |
CA (1) | CA2949447C (fr) |
SG (1) | SG11201609382WA (fr) |
WO (1) | WO2015179864A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019028272A1 (fr) * | 2017-08-04 | 2019-02-07 | Promega Corporation | Compositions et procédés de stabilisation d'analogues de benzothiazole luciférine |
KR20210072040A (ko) | 2018-10-03 | 2021-06-16 | 프로메가 코포레이션 | 코엘렌테라진 및 이의 유사체 및 유도체를 안정화하기 위한 조성물 및 방법 |
CN111116594B (zh) * | 2019-12-03 | 2021-05-28 | 山东大学 | 一种C-6位改造NanoLuc类型类似物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2000622A1 (de) * | 1970-01-08 | 1971-07-22 | Agfa Gevaert Ag | Verfahren zur Stabilisierung von Silberbildern |
JP4639904B2 (ja) * | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
US7718389B2 (en) * | 2006-07-24 | 2010-05-18 | National Institute Of Advanced Industrial Science And Technology | Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity |
JP4761150B2 (ja) * | 2006-07-24 | 2011-08-31 | 独立行政法人産業技術総合研究所 | ハイスループット発光活性測定のためのセレンテラジン(ウミシイタケルシフェリン)溶液の安定化組成物および安定化法 |
JP5774471B2 (ja) * | 2008-03-27 | 2015-09-09 | プロメガ コーポレイションPromega Corporation | シアノベンゾチアゾールコンジュゲートによるタンパク質標識 |
CN106148362B (zh) * | 2010-11-02 | 2021-04-30 | 普罗梅加公司 | 新型腔肠素底物及其使用方法 |
-
2015
- 2015-05-26 US US14/721,727 patent/US9676997B2/en active Active
- 2015-05-26 WO PCT/US2015/032439 patent/WO2015179864A1/fr active Application Filing
- 2015-05-26 CA CA2949447A patent/CA2949447C/fr active Active
- 2015-05-26 AU AU2015263901A patent/AU2015263901B2/en active Active
- 2015-05-26 BR BR112016027504-7A patent/BR112016027504B1/pt active IP Right Grant
- 2015-05-26 EP EP15730321.5A patent/EP3146066B1/fr active Active
- 2015-05-26 CN CN201580026864.3A patent/CN106661028B/zh active Active
- 2015-05-26 JP JP2016569444A patent/JP6641297B2/ja active Active
- 2015-05-26 KR KR1020167033229A patent/KR102456212B1/ko active IP Right Grant
- 2015-05-26 SG SG11201609382WA patent/SG11201609382WA/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3146066A1 (fr) | 2017-03-29 |
CA2949447A1 (fr) | 2015-11-26 |
CN106661028B (zh) | 2021-08-06 |
EP3146066B1 (fr) | 2018-03-14 |
CN106661028A (zh) | 2017-05-10 |
AU2015263901A1 (en) | 2016-11-24 |
KR20170012271A (ko) | 2017-02-02 |
BR112016027504B1 (pt) | 2023-04-18 |
JP2017519977A (ja) | 2017-07-20 |
WO2015179864A1 (fr) | 2015-11-26 |
CA2949447C (fr) | 2022-10-04 |
US9676997B2 (en) | 2017-06-13 |
JP6641297B2 (ja) | 2020-02-05 |
US20150337198A1 (en) | 2015-11-26 |
KR102456212B1 (ko) | 2022-10-20 |
AU2015263901B2 (en) | 2021-03-11 |
BR112016027504A2 (fr) | 2017-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1257295A1 (zh) | 用於免疫腫瘤學的組合物和方法 | |
GB2535253B (en) | Compositions and methods | |
IL248143A0 (en) | Methods and preparations for immune modulation | |
GB2546350B (en) | Compositions and methods | |
IL249446A0 (en) | Preparations and methods for production packaging | |
GB201718876D0 (en) | Antithrombin-heparin compositions and methods | |
IL246879B (en) | Preparations of Epilimod and methods of using them | |
GB201417828D0 (en) | New methods and compositions | |
IL247614A0 (en) | Methods and preparations for changing the immune response | |
HK1245158A1 (zh) | 阿吡莫德組合物及其使用方法 | |
HK1245302A1 (zh) | 載體分子組合物及相關方法 | |
HK1231501A1 (zh) | 氧化鋁組合物和製備其的方法 | |
SG11201701402QA (en) | Anti-tumor compositions and methods | |
EP3097420A4 (fr) | Procédés et compositions de désinhibition immunitaire | |
PT3113774T (pt) | Composições de grapiprant e métodos de utilização das mesmas | |
ZA201703123B (en) | Combination long acting compositions and methods for hepatitis c | |
SG11201609382WA (en) | Compositions and methods for stabilizing luminogenic substrates | |
IL248513A0 (en) | Preparations and methods for immunomodulation against lyst | |
GB201512996D0 (en) | Compositions and methods | |
GB201514413D0 (en) | Compositions and methods | |
PT3160263T (pt) | Composições para prevenção de infeções | |
IL249103B (en) | Compositions and methods for stabilizing luminogenic substrates | |
GB201402915D0 (en) | Compositions and methods | |
IL256261B (en) | Hide1 compositions and methods | |
EP3221366A4 (fr) | Polyaminométhylbenzyloxalamides et compositions et procédés associés |